BELANOVÁ, Renata, Andrea ŠPRLÁKOVÁ-PUKOVÁ, Michal STANDARA, Eva JANŮ, Renata KOUKALOVÁ, Jan KŘÍSTEK, Petr BURKOŇ, Ivana KOLOUŠKOVÁ, Tomáš PROCHÁZKA, Petr POSPÍŠIL, Arnab CHAKRAVARTI, Pavel ŠLAMPA, Ondřej SLABÝ and Tomáš KAZDA. In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region. Biomedical Papers. Olomouc: Palacky University, 2020, vol. 164, No 3, p. 307-313. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2019.039.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region
Authors BELANOVÁ, Renata (203 Czech Republic, belonging to the institution), Andrea ŠPRLÁKOVÁ-PUKOVÁ (203 Czech Republic, belonging to the institution), Michal STANDARA (203 Czech Republic), Eva JANŮ (203 Czech Republic, belonging to the institution), Renata KOUKALOVÁ (203 Czech Republic, belonging to the institution), Jan KŘÍSTEK (203 Czech Republic, belonging to the institution), Petr BURKOŇ (203 Czech Republic, belonging to the institution), Ivana KOLOUŠKOVÁ (203 Czech Republic, belonging to the institution), Tomáš PROCHÁZKA (203 Czech Republic, belonging to the institution), Petr POSPÍŠIL (203 Czech Republic, belonging to the institution), Arnab CHAKRAVARTI, Pavel ŠLAMPA (203 Czech Republic, belonging to the institution), Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Tomáš KAZDA (203 Czech Republic, guarantor, belonging to the institution).
Edition Biomedical Papers, Olomouc, Palacky University, 2020, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.245
RIV identification code RIV/00216224:14110/20:00118197
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2019.039
UT WoS 000595645600013
Keywords in English pseudoprogression; RANO; glioblastoma; radiotherapy; high-dose field
Tags 14110216, 14110811, 14110812, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/2/2021 12:30.
Abstract
Background and Aim. Oncologists play a vital role in the interpretation of radiographic results in glioblastoma patients. Molecular pathology and information on radiation treatment protocols among others are all important for accurate interpretation of radiology images. One important issue that may arise in interpreting such images is the phenomenon of tumor "pseudoprogression"; oncologists need to be able to distinguish this effect from true disease progression. Exact knowledge about the location of high-dose radiotherapy region is needed for valid determination of pseudoprogression according to RANO (Response Assessment in Neuro-Oncology) criteria in neurooncology. The aim of the present study was to evaluate the radiologists' understanding of a radiotherapy high-dose region in routine clinical practice since radiation oncologists do not always report 3-dimensional isodoses when ordering follow up imaging. Methods. Eight glioblastoma patients who underwent postresection radiotherapy were included in this study. Four radiologists worked with their pre-radiotherapy planning MR, however, they were blinded to RT target volumes which were defined by radiation oncologists according to current guidelines. The aim was to draw target volume for high dose RT fields (that is the region, where they would consider that there may be a pseudoprogression in future MRI scans). Many different indices describing structure differences were analyzed in comparison with original per-protocol RT target volumes. Results. The median volume for RT high dose field was 277 ccm (range 218 to 401 ccm) as defined per protocol by radiation oncologist and 87 ccm (range 32-338) as defined by radiologists (median difference of paired difference 31%, range 15-112%).The Median Dice index of similarity was 0.46 (range 0.14- 0.78), the median Hausdorff distance 25 mm. Conclusion. Continuing effort to improve education on specific procedures in RT and in radiology as well as automatic tools for exporting RT targets is needed in order to increase specificity and sensitivity in response evaluation.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV18-03-00398, research and development projectName: Rozšíření současných prognostických skórovacích systémů u mozkových metastáz o mikroRNA profilování s cílem individualizace pooperační péče
Investor: Ministry of Health of the CR, Extension of established prognostic scores in brain metastases by microRNA profiling to tailor the post-operative personalized care
NV18-03-00469, research and development projectName: Reakce neuronální populace hipokampu na stereotaktickou radioterapii extratemporálních mozkových metastáz: vliv na neurokognitivní funkce a zachování kvality života
Investor: Ministry of Health of the CR
PrintDisplayed: 3/5/2024 04:18